Indian PM Modi renews ties with Maldives
Indian Prime Minister Narendra Modi wrapped up a visit to the Maldives on Saturday, renewing ties by offering infrastructure projects and vital financial assistance to the cash-strapped Indian Ocean nation.
Regional powerhouse India had been concerned that its small, yet strategically located neighbour was drifting towards the orbit of its rival China following the 2023 election of President Mohamed Muizzu on an anti-India platform.
Since coming to office, Muizzu has secured the withdrawal of a small contingent of Indian military personnel who operated search-and-rescue aircraft in the archipelago.
But he has since toned down his anti-India rhetoric, and on Friday he touted the two nations' collaboration on security and trade.
"India has long stood as the Maldives' closest and most trusted partner," Muizzu said in a banquet speech alongside Modi, whom he met with twice last year.
"We deeply value the friendship of India and are grateful for the timely assistance your country has extended to us in moments of need," Muizzu added.
Shortly after his arrival on Friday, Modi unveiled a $565 million credit line for the Maldives, which is facing a severe foreign exchange shortage despite its thriving tourism industry.
India also reduced annual repayments of an earlier credit line from $51 million to $29 million, and the two sides discussed a potential free-trade agreement.
Muizzu said the new credit line would bolster the Maldives' security forces, and improve healthcare, housing and education.
During his two-day trip, Modi also inaugurated a new defence ministry headquarters and several India-funded infrastructure projects, including roads and a 4,000-unit housing scheme.
Modi's visit had set "a clear path for the future of Maldives-India relations", Muizzu wrote on X on Saturday as the Indian leader left the capital Male after 60th Independence Day celebrations.
"Our relationship continues to grow, shaped by people-to-people ties and cooperation in various sectors," Modi wrote in his own post on X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
an hour ago
- Business Recorder
Need for Pakistan-India peace dialogue
EDITORIAL: During a recent meeting with British High Commissioner Jane Marriott, Prime Minister Shehbaz Sharif reiterated Pakistan's readiness for 'meaningful dialogue' with India. This expression of willingness comes at a time when bilateral relations have been severely strained by years of tensions, fuelled by the ultranationalist rhetoric of India's Prime Minister Narendra Modi and a recent military confrontation between the two nuclear-armed nations. Since Modi assumed office in 2014, relations between India and Pakistan have sharply deteriorated. Under his leadership, India has seen a surge in rhetoric that not only targets Pakistan but also intensifies hostility towards the country's Muslim minority. This rhetoric has served his government as both a political tool during elections and a cornerstone of foreign policy, significantly diminishing the political space for dialogue or reconciliation with Pakistan—particularly on sensitive issues like Kashmir. The outcome has been a hardening of stance and an increased reliance on military assertiveness. A glaring example of this escalation was the aftermath of the April 22 Pahalgam terror attack. India quickly accused Pakistan of involvement, though it has yet to present compelling evidence to the international community. Shortly thereafter, on May 6, India launched missile and drone strikes deep inside Pakistan, violating international law while claiming to target terrorist hideouts. Prime Minister Modi referred to the extreme provocation as the 'new normal', setting a dangerous precedent that could have spiralled into a full-scale war. Pakistan responded decisively, downing six Indian warplanes, before US President Donald Trump intervened to broker a ceasefire. Left embarrassed by the developments, Modi later stated that India had taken a 'pause' in hostilities. This implied the threat of renewed conflict. Such brinkmanship significantly heightens the risk of miscalculation, especially given that India and Pakistan have fought three wars over Kashmir and quite a few limited confrontations. Continued hostility jeopardises the peace and stability of this region, and beyond. UN Secretary-General António Guterres has, for example, rightly stated, 'The world cannot afford another conflict in South Asia. Both countries must find common ground, even if it means taking small steps toward peace.' PM Sharif's emphasis on 'meaningful' dialogue underscores Pakistan's desire for a structured, result-oriented peace process. It signals Pakistan's willingness to engage constructively on issues of mutual concern, such as counterterrorism, water disputes, and trade. As a matter of fact, for several years in the past both sides had engaged in structured dialogue under the Composite Dialogue framework, addressing a wide-range of issues — including the core issue of Kashmir. From Pakistan's perspective, renewing the peace dialogue is not only possible but essential. However, as long as Modi is at the helm of power, peace with Pakistan remains a distant prospect. His government's hardline stance and focus on zero-sum national security rhetoric leave little room for diplomatic flexibility. Copyright Business Recorder, 2025
Business Recorder
an hour ago
- Business Recorder
Pharmaceutical exports: some prescriptions
'The global pharmaceutical market is in a state of flux due to major restructuring, both in terms of the demand and supply. This presents a unique opportunity for the sector in Pakistan to take timely action by positioning itself strategically to enter the global drugs market. Pakistan is well poised to gain from opportunities provided under these shuffling global patterns of demand and supply'. International Trade Centre study titled Pakistan Export Strategy – Pharmaceuticals 2023-2027. The Pharmaceutical market in Pakistan is estimated at over PKR 1.10 trillion, growing at a rate of over 15 percent according to analysts. There are over 700 pharmaceutical companies from Karachi to Khyber. In Pakistan, 80 percent of the domestic need for medicine is fulfilled by local manufacturing, whereas the other 20 percent is through imports. Most of the imports are essential and crucial drugs that cannot be manufactured locally, and at the present moment not licensed for manufacturing for specific reasons. Pakistan's pharmaceutical exports growth hit a two-decade high of 34 percent in the fiscal year ended June 30, 2025, hitting sales of USD 457 million, whereas in 2024 the exports were USD 341 million. Although the pharma sector is commended for its export performance, nevertheless, Pakistani companies should endeavour to seek new export markets. The pharma exports growth trajectory requires close liaison between the manufacturers and the regulator. The main destinations for Pakistan's pharmaceutical exports are Afghanistan, the Philippines, Uzbekistan, Sri Lanka, Cambodia and recently Iraq. Formidable efforts must be made to carve out a substantial share of the African, Middle East and Central Asia markets. In the same manner as other Pakistani products, the menace of illicit exports of pharma products which in many cases lack quality assurance, use substandard raw material, and are unethically counterfeit, while bringing in undocumented foreign proceeds, result in creating a negative image of the pharma sector. It is recommended that a pharma oversight Council be formed consisting of representatives from SIFC, Anti-Narcotics Force, Army Corps X1 and Corps X11 based in KPK and Balochistan, as well as from the Pakistan Pharmaceuticals Manufacturers Association that would identify those in this illicit trade, seal their premises, and prosecute the owners or perpetrators. This illicit trade is estimated to be around USD 90-100 million annually and is growing every year. It is an accepted fact that exports of pharmaceutical products require compliance with world-class quality assurance standards, maximum focus on health safety standards, and investment in modern technologies, including use of Artificial Intelligence. A solid foundation is imperative in order to claim a stake in the export regime, as this would enable the companies to enhance their competitiveness in the global market. According to Arshad Rahim Khan, an old pro in the pharma industry who has been appointed as TDAP Consultant on pharmaceuticals, 'currently, the sector is underdeveloped, non-compliant with international regulations (cGMP, PICs, ISO, WHO, EU, UK, US), low performing, and hence at a low entry valuation'. Haroon Qasim, a leading pharmaceutical company owner and advocate of instilling the concept of new technology in manufacturing, highlighted the role of digital technologies in revolutionising drug development, patient engagement, and pharmacovigilance. Enlightened entrepreneurs are adopting AI rapidly and are well aware of its importance in new drugs development, in improving safety of consumers, and making a well-intentioned paradigm shift in the healthcare landscape. The Institute of Chartered Accountants of Pakistan, in its study of the pharma sector, stated that 'over 90 percent of the raw material used in making of drug is imported.' Only 12 percent of API is produced in Pakistan. Specialized finished dosage form and biologicals such as vaccines, oncology, etc., continue to be imported. The current practice of importing 95 percent of the raw material, compounding active ingredients with excipients, coating the pills, and packaging the drugs, cannot continue to be the long-term goal of the sector. Heavy import dependency of active ingredients from China and India also poses significant concentration risk. Reliance of local pharmaceutical industry on India was estimated at 50 percent — 60 percent before the recent Indo-Pak conflict. Pakistan Business Council, in a study 'Unleashing the Potential of Pharmaceuticals in Pakistan', advised that 'Drug Regulatory Authority of Pakistan should continue its reforms for quality regulation and enforcement, for example, by achieving international standards, clearing certifications as per WHO Global Benchmarking Tool, and attaining the Pharmaceutical Inspection Corporation Scheme membership, which could allow market access to Stringent Regulatory Authority countries'. The depressing situation is that only four foreign companies have manufacturing facilities in the country. Ayesha T. Haq, Executive Director of Pharma Bureau, emphasized the issues impeding the growth of foreign pharmaceutical companies in Pakistan. 'The regulatory environment in Pakistan is a major obstacle to the growth of foreign pharmaceutical companies. The DRAP Act 2012, Drugs Act 1976, and Drug Pricing Policy 2018, contain numerous anomalies, including overlapping powers, unclear standard operating procedures, and irrational pricing of essential drugs. These issues have led to a lack of confidence among foreign investors.' In a transformative step aimed at modernizing trade and enhancing the global competitiveness of Pakistan's pharmaceutical sector, the Pakistan Single Window, in collaboration with DRAP, officially launched the Digital Certificate of Pharmaceutical Product. This Digital Certificate is designed to streamline cross-border pharmaceutical trade by meeting the documentation and regulatory requirements of importing countries. It replaces traditional paper-based systems with a secure, verifiable, and fully digital solution. The pharma industry must continue the momentum of export growth. A comprehensive and holistic approach is crucial, and this is possible when manufacturers are successful in lobbying and advocating the removal of challenges that hinder rapid growth and are determined to meet the high quality standards of international organizations. Pakistan lacks Bioequivalence Centers that are approved or partnered with major regulatory authorities. An Executive of a leading pharma company disclosed in an email that 'countries like Uzbekistan, Bangladesh, and India provide financial support to their pharmaceutical companies for conducting Bioequivalence studies from internationally accredited or approved centres, enabling faster product registration compared to Pakistani companies'. He further added that 'inconsistent supply and high cost of physical infrastructure, no incentives for companies to upgrade technology by importing the latest machines and equipment, exchange rate volatility, high financial costs, challenges in remittances, and frequent border closures with Afghanistan create significant challenges for export logistics to Afghanistan and CIS regions'. Most of the nearly 700 pharma manufacturers in Pakistan are focused on domestic sales, including to private and public hospitals. They do not have the critical mass to enter the export market. A number of these companies do toll manufacturing for large companies and also may not have any products registered in their names. It is now imperative that these smaller companies are encouraged to enter the export market. One suggestion floated by this writer is that a Collective be formed, initially consisting of around fifty manufacturers. The management of the Collective would be in the hands of technocrats who have in the past served in the pharma sector. The Collective would undertake steps to make these companies compliant with all conditionalities, help in procuring quality certificates, upskill their work force and managerial cadre, liaise with DRAP and other agencies, be the focal point for common procurement of raw material, and create a mutual pool of financial resources for any contingencies. The Collective will procure export orders and farm out these orders as per the facilities available in these enterprises. The pharmaceuticals would be exported under one brand and logo (say, Dawaa-Pak). However, the name of the unit could be mentioned in the packaging. The administrative expenses should be less than seven percent of the net profit, ten percent would be deposited in an escrow account in case of future needs, while eighty percent would be deposited in the member company accounts. If the enterprise has excess capacity to do toll manufacturing or direct selling, these should also be encouraged. The Collective can organize single country, single brand exhibitions in different countries such as Sri Lanka, in Africa, and in Central Asian States. An annual export target must be decided and TDAP should facilitate the project. If the idea of the Collective catches on, more enterprises who desire to enter exports could be inducted. It is imperative that smaller companies get on the bandwagon so that together, along with large manufacturers, they can soon achieve the target of USD 1 billion in national pharma exports. Over five centuries ago, Swiss physician and alchemist Paracelsus said, 'Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided.' (The writer is a former President, Karachi Chamber of Commerce and Industry) Copyright Business Recorder, 2025
Business Recorder
an hour ago
- Business Recorder
Old car importers: Anti-Benami zone of FBR initiates big crackdown
KARACHI: The anti-Benami zone of Federal Board of Revenue (FBR) has kicked off massive crackdown against the billions of rupees Benami transactions carried out by old/used car importers during past seven years. According to the official document, which was exclusively available to the Daily Business Recorder, the anti-Benami zone has launched a comprehensive crackdown targeting the systematic abuse of the Vehicle Baggage and Gifts Scheme (VB&GS), which was designed for legitimate personal imports but has been extensively exploited by commercial importers through clearing agents with the alleged support of customs officials. The enforcement action is focusing on vehicle clearances conducted between February 2018 and May 2025, giving clearing agents just seven days to provide detailed explanations for thousands of vehicle imports processed under the personal baggage scheme. The notices have specifically accused clearing agents of concealing the true beneficial ownership of imported vehicles while systematically evading billions in taxes and duties during the seven-year period under investigation. The anti-Benami zone has demanded comprehensive documentation from clearing agents, including complete import records, customs declarations, detailed particulars of end users and true owners with names, national identity card numbers and addresses, information on all parties involved in transactions, copies of agreements and contracts, bank statements covering the entire seven-year period, and detailed explanations of how commercial vehicles qualified for the personal baggage and gifts scheme and warned to initiate criminal proceedings under multiple sections of the Benami Transactions (Prohibition) Act 2017 in case of non-compliance, showing the determination to hold all responsible accountable for this systematic exploitation of these schemes. Arshad Khurshid, Chairman of the All Pakistan Customs Clearing Agents Association, confirmed that the anti-Benami zone has issued notices to the association members involved in vehicles clearance. He said that the association has instructed its members to provide maximum cooperation with the investigation and furnish all requested clearance records to the authorities. Meanwhile sources informed that the crackdown was initiated following direct instructions from Prime Minister Shahbaz Sharif, who ordered comprehensive action to stop the exploitation of overseas Pakistani passports for misusing personal baggage, transfer of residence, and gift schemes in the import of old/ used vehicles. The Prime Minister's directive is now reflecting zero-tolerance approach against the systematic abuse of schemes, which although intended to facilitate overseas Pakistanis for their legitimate personal imports, being misused for years. The government had previously attempted to address the issue by introducing additional legal requirements in the Import Policy Order, 2022, implemented in 2019 for old/used vehicle imports under these schemes. These regulations mandated that all duties and taxes for vehicles imported under transfer of residence, personal baggage, or gift schemes must be paid using foreign exchange arranged by Pakistani nationals themselves or local recipients, supported by bank encashment certificates showing conversion of foreign remittance to local currency. It also restricted that remittances for duty and tax payments must originate from the account of the Pakistani national sending the vehicle from abroad, and must be received either in the sender's account or, if that account is non-existent or inoperative, in a family member's account. To ensure compliance, the government made submission of Proceed Realization Certificates mandatory, including details of remitting banks, remitter names, beneficiary information, account numbers, certificate amounts, and beneficiary banks verified by head offices. However, customs authorities have found a new pattern of fraud where unscrupulous elements involved in vehicle clearance have been submitting fake Proceed Realization Certificates in collusion with various private banks. These fraudulent certificates were being verified by the banks themselves, enabling the illegal clearance of vehicles, sources said, suggesting that the ongoing crackdown may not have lasting impact without comprehensive policy reform. They said that the government collected over Rs. 100 billion through old/used vehicle imports but didn't promulgate any policy for commercial imports, urging the government to introduce a commercial import policy to completely eliminate such illicit activities. Copyright Business Recorder, 2025
